Seattle Genetics Cancer-Drug Trials on Hold After Four Patient Deaths

Seattle Genetics Inc. said the U.S. Food and Drug Administration had placed several of its early-stage cancer drug trials on hold after four patients died during treatment.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: PAID Source Type: news